Dasatinib for HIV-1 Reservoir Reduction

NCT07342491 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

14

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Dasatinib
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)